Vertex Pharmaceuticals Incorporated (VRTX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 2.99B | 3.23B | 3.08B | 2.96B | 2.77B | 2.91B | 2.77B | 2.65B | 2.69B | 2.52B | 2.48B | 2.49B | 2.37B | 2.3B | 2.33B | 2.2B | 2.1B | 2.07B | 1.98B | 1.79B |
| Revenue Growth % | 7.82% | 10.82% | 10.99% | 12.06% | 3.09% | 15.66% | 11.61% | 6.11% | 13.15% | 9.34% | 6.39% | 13.52% | 13.22% | 11.1% | 17.65% | 22.46% | 21.64% | 27.32% | 28.99% | 17.64% |
| Cost of Goods Sold | 392.8M | 466M | 414.8M | 407.5M | 363M | 423.4M | 392.6M | 371.9M | 342.6M | 368M | 318.7M | 308.6M | 266.9M | 283.3M | 289.4M | 261.8M | 245.8M | 247.4M | 236.51M | 227.97M |
| COGS % of Revenue | 13.15% | 14.44% | 13.48% | 13.75% | 13.1% | 14.54% | 14.16% | 14.06% | 12.75% | 14.62% | 12.83% | 12.38% | 11.24% | 12.3% | 12.4% | 11.92% | 11.72% | 11.94% | 11.92% | 12.71% |
| Gross Profit | 2.59B | 2.76B | 2.66B | 2.56B | 2.41B | 2.49B | 2.38B | 2.27B | 2.34B | 2.15B | 2.16B | 2.18B | 2.11B | 2.02B | 2.04B | 1.93B | 1.85B | 1.83B | 1.75B | 1.57B |
| Gross Margin % | 86.85% | 85.56% | 86.52% | 86.25% | 86.9% | 85.46% | 85.84% | 85.94% | 87.25% | 85.38% | 87.17% | 87.62% | 88.76% | 87.7% | 87.6% | 88.08% | 88.28% | 88.06% | 88.08% | 87.29% |
| Gross Profit Growth % | 7.76% | 10.95% | 11.86% | 12.47% | 2.67% | 15.77% | 9.91% | 4.08% | 11.23% | 6.45% | 5.86% | 12.93% | 13.84% | 10.64% | 17.01% | 23.57% | 20.87% | 28.11% | 29.26% | 16.82% |
| Operating Expenses | 1.46B | 1.46B | 1.48B | 1.41B | 1.78B | 1.46B | 1.26B | 5.79B | 1.21B | 1.16B | 1.13B | 1.16B | 1.33B | 985.9M | 918.2M | 828.1M | 810.8M | 949.5M | 691.94M | 1.6B |
| OpEx % of Revenue | 48.75% | 45.26% | 47.96% | 47.43% | 64.15% | 50.23% | 45.56% | 218.79% | 44.97% | 46.12% | 45.32% | 46.48% | 55.96% | 42.81% | 39.34% | 37.71% | 38.66% | 45.81% | 34.87% | 89.4% |
| Selling, General & Admin | 493.7M | 487M | 445.1M | 424.6M | 396.4M | 377.6M | 371.8M | 372.2M | 342.7M | 369.1M | 263.8M | 262.6M | 241.1M | 267.4M | 246.8M | 215.3M | 215.2M | 255.2M | 198.19M | 194.6M |
| SG&A % of Revenue | 16.53% | 15.09% | 14.47% | 14.32% | 14.31% | 12.97% | 13.41% | 14.07% | 12.75% | 14.66% | 10.62% | 10.53% | 10.15% | 11.61% | 10.57% | 9.8% | 10.26% | 12.31% | 9.99% | 10.85% |
| Research & Development | 961.6M | 973.7M | 1.03B | 978.4M | 979.7M | 998.7M | 875.9M | 5.42B | 865.9M | 1.35B | 861.7M | 896.2M | 742.6M | 694.1M | 645M | 600.1M | 603.1M | 694.3M | 493.75M | 1.41B |
| R&D % of Revenue | 32.19% | 30.17% | 33.55% | 33% | 35.37% | 34.3% | 31.6% | 204.71% | 32.22% | 53.69% | 34.7% | 35.95% | 31.27% | 30.14% | 27.63% | 27.32% | 28.75% | 33.5% | 24.88% | 78.46% |
| Other Operating Expenses | 700K | 0 | -1000K | 1000K | 1000K | 1000K | 1000K | 500K | -100K | -1000K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 0 | 0 | 1000K |
| Operating Income | 1.14B | 1.3B | 1.19B | 1.15B | 630.1M | 1.03B | 1.12B | -3.51B | 1.14B | 988.5M | 1.04B | 1.03B | 779M | 1.03B | 1.13B | 1.11B | 1.04B | 877.7M | 1.05B | -37.9M |
| Operating Margin % | 38.1% | 40.3% | 38.56% | 38.83% | 22.75% | 35.23% | 40.27% | -132.85% | 42.4% | 39.26% | 41.8% | 41.17% | 32.8% | 44.88% | 48.27% | 50.37% | 49.63% | 42.35% | 53.15% | -2.11% |
| Operating Income Growth % | 80.62% | 26.74% | 6.26% | 132.75% | -44.7% | 3.79% | 7.53% | -442.43% | 46.28% | -4.35% | -7.86% | -7.22% | -25.16% | 17.75% | 6.85% | 3019% | 17.24% | 17.69% | 56.87% | -105.28% |
| EBITDA | 1.14B | 1.35B | 1.24B | 1.2B | 678.5M | 1.07B | 1.17B | -3.46B | 1.19B | 1.05B | 1.08B | 1.07B | 817.8M | 1.07B | 1.16B | 1.14B | 1.08B | 911.53M | 1.09B | -6.6M |
| EBITDA Margin % | 38.1% | 41.94% | 40.31% | 40.57% | 24.49% | 36.83% | 42.19% | -130.81% | 44.4% | 41.61% | 43.5% | 42.83% | 34.44% | 46.55% | 49.84% | 52.07% | 51.34% | 43.98% | 54.74% | -0.37% |
| EBITDA Growth % | 67.74% | 26.2% | 6.05% | 134.76% | -43.13% | 2.39% | 8.27% | -424.1% | 45.88% | -2.28% | -7.15% | -6.63% | -24.05% | 17.59% | 7.11% | 17427.27% | 17.47% | 17.59% | 55.42% | -100.89% |
| D&A (Non-Cash Add-back) | 0 | 53.1M | 54M | 51.7M | 48.4M | 46.5M | 53.2M | 54M | 53.5M | 59M | 42.1M | 41.4M | 38.8M | 38.4M | 36.7M | 37.3M | 35.9M | 33.83M | 31.7M | 31.3M |
| EBIT | 1.14B | 1.3B | 1.3B | 1.29B | 733.4M | 1.14B | 1.23B | -3.38B | 1.29B | 1.16B | 1.19B | 1.17B | 902.9M | 1.09B | 1.19B | 1.04B | 969.7M | 886.04M | 1.1B | -28.7M |
| Net Interest Income | 114.8M | 118.6M | 122.4M | 118.7M | 117.9M | 125.4M | 124.7M | 146.6M | 170.8M | 168.9M | 157M | 133.5M | 111.2M | 74.4M | 32.5M | -3.8M | -13.3M | -13.9M | -14.1M | -14.4M |
| Interest Income | 114.8M | 121.9M | 125.7M | 122.4M | 120.9M | 128.2M | 132.2M | 156.5M | 181.2M | 179.5M | 167.9M | 144.7M | 122.6M | 86M | 46.2M | 10.8M | 1.6M | 1.2M | 1.12M | 1.13M |
| Interest Expense | 0 | 3.3M | 3.3M | 3.7M | 3M | 2.8M | 7.5M | 9.9M | 10.4M | 10.6M | 10.9M | 11.2M | 11.4M | 11.6M | 13.7M | 14.6M | 14.9M | 15.1M | 15.26M | 15.48M |
| Other Income/Expense | 114.8M | 30.6M | 112.6M | 131.9M | 100.3M | 110.5M | 107.8M | 123.5M | 139.6M | 159.1M | 141.1M | 135.1M | 112.5M | 43.3M | 49.7M | -81.9M | -86.1M | -6.82M | 28.3M | -6.3M |
| Pretax Income | 1.25B | 1.33B | 1.3B | 1.28B | 730.4M | 1.14B | 1.22B | -3.39B | 1.28B | 1.15B | 1.18B | 1.16B | 891.5M | 1.08B | 1.18B | 1.02B | 954.8M | 870.9M | 1.08B | -44.2M |
| Pretax Margin % | 41.95% | 41.24% | 42.22% | 43.28% | 26.37% | 39.03% | 44.16% | -128.18% | 47.6% | 45.58% | 47.48% | 46.59% | 37.54% | 46.76% | 50.4% | 46.64% | 45.52% | 42.02% | 54.57% | -2.46% |
| Income Tax | 221.5M | 139.9M | 215.9M | 250.1M | 84.1M | 223.5M | 178.7M | 202.4M | 179.5M | 178.8M | 143.9M | 245.8M | 191.7M | 257.9M | 245.9M | 213.9M | 192.7M | 100.8M | 230.81M | -111.18M |
| Effective Tax Rate % | 17.68% | 10.51% | 16.62% | 19.49% | 11.51% | 19.67% | 14.6% | -5.97% | 14.03% | 15.58% | 12.2% | 21.16% | 21.5% | 23.95% | 20.9% | 20.88% | 20.18% | 11.57% | 21.32% | 251.54% |
| Net Income | 1.03B | 1.19B | 1.08B | 1.03B | 646.3M | 913M | 1.05B | -3.59B | 1.1B | 968.8M | 1.04B | 915.7M | 699.8M | 818.9M | 930.5M | 810.5M | 762.1M | 770.1M | 851.93M | 66.92M |
| Net Margin % | 34.53% | 36.91% | 35.2% | 34.84% | 23.33% | 31.35% | 37.71% | -135.83% | 40.92% | 38.48% | 41.69% | 36.73% | 29.47% | 35.56% | 39.86% | 36.9% | 36.33% | 37.16% | 42.94% | 3.73% |
| Net Income Growth % | 59.59% | 30.46% | 3.59% | 128.74% | -41.22% | -5.76% | 0.98% | -492.44% | 57.13% | 18.3% | 11.26% | 12.98% | -8.17% | 6.34% | 9.22% | 1111.08% | 16.68% | 27.46% | 27.64% | -92.01% |
| Net Income (Continuing) | 1.03B | 1.19B | 1.08B | 1.03B | 646.3M | 913M | 1.05B | -3.59B | 1.1B | 968.8M | 1.04B | 915.7M | 699.8M | 818.9M | 930.5M | 810.5M | 762.1M | 770.1M | 851.93M | 66.92M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 4.02 | 4.65 | 4.20 | 3.99 | 2.49 | 3.50 | 4.01 | -13.92 | 4.21 | 3.71 | 3.97 | 3.52 | 2.69 | 3.15 | 3.59 | 3.13 | 2.96 | 3.00 | 3.28 | 0.26 |
| EPS Growth % | 61.45% | 32.86% | 4.74% | 128.66% | -40.86% | -5.66% | 1.01% | -495.45% | 56.51% | 17.78% | 10.59% | 12.46% | -9.12% | 5% | 9.45% | 1103.85% | 18.88% | 30.43% | 29.64% | -91.82% |
| EPS (Basic) | 4.06 | 4.69 | 4.24 | 4.02 | 2.52 | 3.55 | 4.05 | -13.92 | 4.26 | 3.76 | 4.01 | 3.55 | 2.72 | 3.19 | 3.63 | 3.17 | 2.99 | 3.02 | 3.30 | 0.26 |
| Diluted Shares Outstanding | 256.3M | 256.1M | 257.6M | 258.9M | 259.5M | 260.5M | 261M | 258.1M | 261.1M | 260.9M | 260.6M | 260.4M | 260.3M | 260.3M | 259.5M | 258.7M | 257.9M | 257M | 259.71M | 261.02M |
| Basic Shares Outstanding | 254.1M | 253.9M | 255.6M | 256.7M | 256.9M | 257.5M | 258M | 258.1M | 258.2M | 257.7M | 258M | 257.7M | 257.4M | 256.9M | 256.5M | 255.9M | 255.1M | 254.6M | 257.88M | 258.99M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |